Skip to main content

Thermo Fisher Scientific Q3 FY2026 results

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

Thermo Fisher Scientific reported revenue of $12.1 billion, up 9.1% from a year earlier, net income of $1.72 billion and diluted earnings per share of $4.64 against $4.27 for the third quarter of fiscal 2026 (the three months to 26 Sep 2026).

From its quarterly report, the results first announced on 21 Oct 2026. Compiled and checked by AapWire.

Q3 FY2026 against Q3 FY2025

Three months to 26 Sep 2026, against the three months to 27 Sep 2025. Amounts in USD.

Thermo Fisher Scientific Q3 FY2026 results against the year-ago quarter
MeasureQ3 FY2026Q3 FY2025Change
Revenue$12.14B$11.12B+9.1%
Gross profit$5.13B$4.58B+12.0%
Gross margin42.3%41.2%+1.1 pts
Operating income$2.26B$1.94B+16.6%
Operating margin18.6%17.5%+1.2 pts
Net income$1.72B$1.62B+6.5%
Diluted EPS$4.64$4.27+8.7%
Operating cash flow$2.55B$2.24B+13.9%
Capital expenditure$437.0M$404.0M+8.2%
Free cash flow$2.11B$1.83B+15.1%

Operating KPIs for the quarter

Earlier quarters

Thermo Fisher Scientific results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q3 FY202626 Sep 2026$12.14B+9.1%$4.64
Q2 FY202627 Jun 2026$11.99B+10.5%$4.68
Q1 FY202628 Mar 2026$11.01B+6.2%$4.43
Q4 FY202531 Dec 2025$12.21B+7.2%$5.21
Q3 FY202527 Sep 2025$11.12B+4.9%$4.27
Q2 FY202528 Jun 2025$10.86B+3.0%$4.28
Q1 FY202529 Mar 2025$10.36B+0.2%$3.98
Q4 FY202431 Dec 2024$11.39B+4.7%$4.78

More on Thermo Fisher Scientific: financial statements · revenue · earnings per share

TMO's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.